Mycobacterium tuberculosis Triggers Host Type I IFN Signaling To Regulate IL-1β Production in Human Macrophages

Mycobacterium tuberculosis is a virulent intracellular pathogen that survives in macrophages even in the presence of an intact adaptive immune response. Type I IFNs have been shown to exacerbate tuberculosis in mice and to be associated with disease progression in infected humans. Nevertheless, the mechanisms by which type I IFNs regulate the host response to M. tuberculosis infection are poorly understood. In this study, we show that M. tuberculosis induces an IFN-related gene expression signature in infected primary human macrophages, which is dependent on host type I IFN signaling as well as the mycobacterial virulence factor, region of difference-1. We further demonstrate that type I IFNs selectively limit the production of IL-1β, a critical mediator of immunity to M. tuberculosis. This regulation occurs at the level of IL1B mRNA expression, rather than caspase-1 activation or autocrine IL-1 amplification and appears to be preferentially used by virulent mycobacteria since avirulent M. bovis bacillus Calmette-Guérin (BCG) fails to trigger significant expression of type I IFNs or release of mature IL-1β protein. The latter property is associated with decreased caspase-1–dependent IL-1β maturation in the BCG-infected macrophages. Interestingly, human monocytes in contrast to macrophages produce comparable levels of IL-1β in response to either M. tuberculosis or BCG. Taken together, these findings demonstrate that virulent and avirulent mycobacteria employ distinct pathways for regulating IL-1β production in human macrophages and reveal that in the case of M. tuberculosis infection the induction of type I IFNs is a major mechanism used for this purpose.

[1]  Pedro Romero,et al.  Type I interferon inhibits interleukin-1 production and inflammasome activation. , 2011, Immunity.

[2]  L. Ivashkiv,et al.  Suppression of TNF-α and IL-1 Signaling Identifies a Mechanism of Homeostatic Regulation of Macrophages by IL-27 , 2010, The Journal of Immunology.

[3]  G. Trinchieri,et al.  Type I interferon: friend or foe? , 2010, The Journal of experimental medicine.

[4]  G. Allmaier,et al.  Tyrosine Kinase 2 Controls IL-1β Production at the Translational Level , 2010, The Journal of Immunology.

[5]  S. Behar,et al.  Evasion of innate immunity by Mycobacterium tuberculosis: is death an exit strategy? , 2010, Nature Reviews Microbiology.

[6]  N. Hacohen,et al.  Mycobacterium tuberculosis protein ESAT‐6 is a potent activator of the NLRP3/ASC inflammasome , 2010, Cellular microbiology.

[7]  R. Vance,et al.  Induction of type I interferons by bacteria , 2010, Cellular microbiology.

[8]  Virginia Pascual,et al.  An Interferon-Inducible Neutrophil-Driven Blood Transcriptional Signature in Human Tuberculosis , 2010, Nature.

[9]  A. Sher,et al.  Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population. , 2010, The Journal of clinical investigation.

[10]  R. Carano,et al.  Host-Detrimental Role of Esx-1-Mediated Inflammasome Activation in Mycobacterial Infection , 2010, PLoS pathogens.

[11]  D. Metzger,et al.  Type I IFN Signaling Constrains IL-17A/F Secretion by γδ T Cells during Bacterial Infections , 2010, The Journal of Immunology.

[12]  A. Sher,et al.  Cutting Edge: Caspase-1 Independent IL-1β Production Is Critical for Host Resistance to Mycobacterium tuberculosis and Does Not Require TLR Signaling In Vivo , 2010, The Journal of Immunology.

[13]  C. Harding,et al.  Regulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptors , 2010, Nature Reviews Microbiology.

[14]  Leo A. B. Joosten,et al.  IL-1β Processing in Host Defense: Beyond the Inflammasomes , 2010, PLoS pathogens.

[15]  M. Quail,et al.  Tuberculous Granuloma Induction via Interaction of a Bacterial Secreted Protein with Host Epithelium , 2010, Science.

[16]  Jianping Jin,et al.  IFN-β Inhibits Human Th17 Cell Differentiation1 , 2009, The Journal of Immunology.

[17]  Chao-Hung Hung,et al.  Successful antiviral and antituberculosis treatment with pegylated interferon-alfa and ribavirin in a chronic hepatitis C patient with pulmonary tuberculosis. , 2009, Journal of the Formosan Medical Association = Taiwan yi zhi.

[18]  D. Portnoy,et al.  Patterns of pathogenesis: discrimination of pathogenic and nonpathogenic microbes by the innate immune system. , 2009, Cell host & microbe.

[19]  I. Kawamura,et al.  The RD1 Locus in the Mycobacterium tuberculosis Genome Contributes to Activation of Caspase-1 via Induction of Potassium Ion Efflux in Infected Macrophages , 2009, Infection and Immunity.

[20]  S. Fortune,et al.  NOD2, RIP2 and IRF5 Play a Critical Role in the Type I Interferon Response to Mycobacterium tuberculosis , 2009, PLoS pathogens.

[21]  L. Joosten,et al.  Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages. , 2009, Blood.

[22]  E. Brown,et al.  ESX‐1‐dependent cytolysis in lysosome secretion and inflammasome activation during mycobacterial infection , 2008, Cellular microbiology.

[23]  S. Ehlers,et al.  Mycobacterium tuberculosis prevents inflammasome activation. , 2008, Cell host & microbe.

[24]  F. Martinon,et al.  Linking inflammasome activation and phagosome maturation. , 2008, Cell host & microbe.

[25]  Jennifer L. Osborn,et al.  Direct multiplexed measurement of gene expression with color-coded probe pairs , 2008, Nature Biotechnology.

[26]  M. Kelliher,et al.  NOD2 Pathway Activation by MDP or Mycobacterium tuberculosis Infection Involves the Stable Polyubiquitination of Rip2* , 2007, Journal of Biological Chemistry.

[27]  Wilbert Bitter,et al.  Type VII secretion — mycobacteria show the way , 2007, Nature Reviews Microbiology.

[28]  B. Ryffel,et al.  IL-1 Receptor-Mediated Signal Is an Essential Component of MyD88-Dependent Innate Response to Mycobacterium tuberculosis Infection , 2007, The Journal of Immunology.

[29]  S. Pestka The Interferons: 50 Years after Their Discovery, There Is Much More to Learn* , 2007, Journal of Biological Chemistry.

[30]  I. Orme,et al.  The Hypervirulent Mycobacterium tuberculosis Strain HN878 Induces a Potent TH1 Response followed by Rapid Down-Regulation1 , 2007, The Journal of Immunology.

[31]  D. Monack,et al.  Type I interferon signaling is required for activation of the inflammasome during Francisella infection , 2007, The Journal of experimental medicine.

[32]  J. Johndrow,et al.  The Type I IFN Response to Infection with Mycobacterium tuberculosis Requires ESX-1-Mediated Secretion and Contributes to Pathogenesis1 , 2007, The Journal of Immunology.

[33]  A. Sher,et al.  NK Cell-Derived IFN-γ Differentially Regulates Innate Resistance and Neutrophil Response in T Cell-Deficient Hosts Infected with Mycobacterium tuberculosis , 2006, The Journal of Immunology.

[34]  R. Manfredi,et al.  Reactivation of severe, acute pulmonary tuberculosis during treatment with pegylated interferon-alpha and ribavirin for chronic HCV hepatitis , 2006, Scandinavian journal of infectious diseases.

[35]  G. Kaplan,et al.  Hypervirulent M. tuberculosis W/Beijing strains upregulate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway. , 2005, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[36]  Christopher M Hickey,et al.  Expression of Many Immunologically Important Genes in Mycobacterium tuberculosis-Infected Macrophages Is Independent of Both TLR2 and TLR4 but Dependent on IFN-αβ Receptor and STAT11 , 2005, The Journal of Immunology.

[37]  C. Hidaka,et al.  Homeostatic Role of Interferons Conferred by Inhibition of IL-1-Mediated Inflammation and Tissue Destruction , 2005, The Journal of Immunology.

[38]  S. Falkow,et al.  Persistent bacterial infections: the interface of the pathogen and the host immune system , 2004, Nature Reviews Microbiology.

[39]  S. Fortune,et al.  Mycobacterium tuberculosis Inhibits Macrophage Responses to IFN-γ through Myeloid Differentiation Factor 88-Dependent and -Independent Mechanisms1 , 2004, The Journal of Immunology.

[40]  D. Sherman,et al.  The secret lives of the pathogenic mycobacteria. , 2003, Annual review of microbiology.

[41]  J. Ernst,et al.  Mycobacterium tuberculosis Exerts Gene-Selective Inhibition of Transcriptional Responses to IFN-γ Without Inhibiting STAT1 Function1 , 2003, The Journal of Immunology.

[42]  Damien Chaussabel,et al.  Unique gene expression profiles of human macrophages and dendritic cells to phylogenetically distinct parasites. , 2003, Blood.

[43]  Priscille Brodin,et al.  Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti , 2002, Molecular microbiology.

[44]  E. Coccia,et al.  Selective Expression of Type I IFN Genes in Human Dendritic Cells Infected with Mycobacterium tuberculosis1 , 2002, The Journal of Immunology.

[45]  G. Kaplan,et al.  Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-α/β , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[46]  G. Mahairas,et al.  Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis , 1996, Journal of bacteriology.

[47]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[48]  P. Ghezzi,et al.  IL-1 induces IL-1. IV. IFN-gamma suppresses IL-1 but not lipopolysaccharide-induced transcription of IL-1. , 1990, Journal of immunology.

[49]  P. Libby,et al.  Interleukin 1 induces interleukin 1. I. Induction of circulating interleukin 1 in rabbits in vivo and in human mononuclear cells in vitro. , 1987, Journal of immunology.